Oxford Finance provided a $60 million senior secured term loan for RxSight, a privately-held MedTech company that commercialized an FDA-approved adjustable intraocular lens that is customized after cataract surgery.
Oxford Finance closed a $15 million senior secured term loan with Vedanta Biosciences, a clinical-stage biopharmaceutical company developing a new category of therapies for immune-mediated diseases based on defined bacterial consortia.
Selecta Biosciences entered into a debt financing facility for up to $35 million with Oxford Finance and Silicon Valley Bank. Selecta will use the financing to retire $12.6 million of existing debt, to advance its ImmTOR pipeline and for business development activities.
Specialty finance firm Oxford Finance closed a $20 million senior secured term loan for AliveCor, a privately held company focused on using artificial intelligence to improve cardiac care.
Oxford Finance closed a $25 million senior secured term loan with Karius, a life science company focused on transforming infectious disease diagnostics with genomics.